Medical Device Market Analysis

• Strategic Analysis of Siemens Healthineers' Naeotom Alpha Photon Counting CT (PCCT) Scanner:
• Methodologies & Sources: Employed competitive intelligence frameworks, using sources like annual reports, company’s websites, clinical publications, technologies journals, industry reports. Leveraged data from key healthcare databases e.g., PubMed, NCBI, FDA, industry news portals etc., to assess PCCT’s impact
• Scope & Approach: Focused on analyzing technological differentiation of Naeotom Alpha and its market implications. Evaluated potential threats and opportunities for Big-4 client, covering product strategy, market positioning, and long-term roadmap. Developed recommendations based on market dynamics and competitor benchmarking
• Conclusions: Identified PCCT as a disruptive force in diagnostic imaging, with key threats to traditional CT players. Recommended a proactive competitive response, including advanced technology development, targeted marketing, and product differentiation to safeguard client market share and relevance

Pharmaceutical Market Analysis

• Competitive Analysis for Teva's Biosimilars Portfolio:
• Methodologies & Sources: Utilized competitive intelligence frameworks, SWOT analysis, and data from regulatory databases (FDA, EMA), clinical trial registries, and industry news platforms to analyze Teva’s biosimilar capabilities. Conducted comparative benchmarking using publicly available drug profiles and market performance data
• Scope & Approach: Developed a Teva company profile with a focus on its biosimilar portfolio. Analyzed recent U.S. biosimilar news, created an impact assessment, and benchmarked Teva’s Humira biosimilar against leading competitors. Mapped regulatory pathways and outlined a competitive intelligence (CI) process flow with deliverable timelines
• Conclusions: Provided strategic insights for Teva’s competitive positioning in biosimilars, highlighting market impact, regulatory considerations, and competitive landscape setup, with actionable recommendations for maintaining market edge

Life Science Market Analysis

• Life Science Tools & Services Market Assessment and Unchained Labs Profiling:
• Methodologies & Sources: Utilized market intelligence tools, competitive analysis frameworks, and sources such as industry reports, annual reports, investor presentations, Factiva
• Scope & Approach: Assessed the market size, segmentation, growth drivers, and challenges. Analyzed competitive landscape, business models, and emerging trends, with a focus on Unchained Labs company’s market positioning and future outlook
• Conclusions: Identified Unchained Labs as a growing player with strong positioning in niche, high-growth segments. Recommended strategies for market differentiation and highlighted future opportunities in technology-driven solutions for broader end-market applications

Therapeutic Area Analysis

• Plaque Psoriasis & IL-17 Inhibitors (Secukinumab/Cosentyx) Competitive Landscape:
• Methodologies & Sources: Conducted disease landscape, market positioning, competitive analysis using primary sources like clinical trial databases (CT.gov, PubMed), regulatory filings (FDA, EMA), FDA labels, company websites, and industry reports
• Scope & Approach: Analyzed plaque psoriasis pathogenesis, patient journey, and treatment evolution, with a focus on IL-17 inhibitors. Assessed Cosentyx’s mechanism, approval timeline, and development pipeline, comparing it with competitors
• Conclusions: Identified Cosentyx’s positioning as a market leader among IL-17 inhibitors and highlighted strategic opportunities for differentiation based on efficacy and patient outcomes